1. Home
  2. BDC vs RGEN Comparison

BDC vs RGEN Comparison

Compare BDC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belden Inc

BDC

Belden Inc

HOLD

Current Price

$130.16

Market Cap

5.6B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$122.23

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDC
RGEN
Founded
1902
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.6B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
BDC
RGEN
Price
$130.16
$122.23
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$148.33
$172.91
AVG Volume (30 Days)
244.3K
758.0K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
0.15%
N/A
EPS Growth
23.13
286.96
EPS
5.91
0.86
Revenue
$2,715,194,000.00
$141,236,000.00
Revenue This Year
$8.91
$14.30
Revenue Next Year
$4.70
$14.52
P/E Ratio
$22.05
$142.76
Revenue Growth
10.33
35.10
52 Week Low
$90.99
$109.66
52 Week High
$159.99
$175.77

Technical Indicators

Market Signals
Indicator
BDC
RGEN
Relative Strength Index (RSI) 62.77 53.95
Support Level $124.37 $121.25
Resistance Level $131.49 $130.56
Average True Range (ATR) 3.85 4.59
MACD 2.44 1.72
Stochastic Oscillator 96.80 98.50

Price Performance

Historical Comparison
BDC
RGEN

About BDC Belden Inc

Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: